Incidence of the pneumoconioses in the United Kingdom general population between 1997 and 2008

Respiration

Volumn 84, Issue 3, 2012, Pages 200-206

  Amar, Rajeev K ^a,b   Jick, Susan S ^d   Rosenberg, Daniel ^c   Maher, Toby M ^e,f,g   Meier, Christoph R ^a,d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c ACTELION PHARMACEUTICALS LTD   (Switzerland)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Asbestosis; Epidemiology; Incidence; Interstitial lung disease; Pneumoconioses

Indexed keywords

ASBESTOS;

ADULT; AGE; AGED; AGING; ASBESTOSIS; FEMALE; GENDER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON ASBESTOS RELATED PNEUMOCONIOSIS; PNEUMOCONIOSIS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; UNITED KINGDOM;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PNEUMOCONIOSIS; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 84866018630     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000338116     Document Type: Review

References (18)

1. Roggli VL, Buttnor KJ: Pneumoconioses; in Leslie KO, Wick MR (eds): Practical Pulmonary Pathology: A Diagnostic Approach. Philadelphia, Churchill-Livingstone, 2005, pp 303-333.
2. Fishwick D: Pneumoconiosis. Medicine 2008; 36:258-260. (Pubitemid 351618065)
3. Health and Safety Executive: Pneumoconio-sis and Silicosis. http://www.hse.gov.uk/statistics/causdis/pneumoconiosis.
4. McNamee R, Carder M, Chen Y, Agius R: Measurement of trends in incidence of work-related skin and respiratory diseases, UK 1996-2005. Occup Environ Med 2008; 65: 808-814.
5. Garcia Rodriquez L, Perez Gutthann S: Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998; 45:419-425. (Pubitemid 28227341)
6. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodríguez LA, Ruigómez A, Meier CR, Schlienger RG, Black C, Jick H: Validity of the General Practice Research Database. Pharmacot herapy 2003; 23: 686-689. (Pubitemid 36539051)
7. Gribbin J, Hubbard RB, Jeune IL, Smith CJP, West J, Tata LJ: Incidence and mortality of idiopathic pulmonary fibrosis and sarcoid-osis in the UK. Thorax 2006; 61:980-985. (Pubitemid 44787169)
8. Hansell A, Hollowell J, Nichols T, McNiece R, Strachan D: Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax 1999; 54:413-419. (Pubitemid 29199779)
9. O'Reilly KM, Mclaughlin AM, Beckett WS, Sime PJ: Asbestos-related lung disease. Am Fam Physician 2007; 75: 683-688.
10. Mesothelioma mortality in Great Britain: estimating the future burden. A report by the Health and Safety Executive. http://www.hse. gov.uk/statistics/ causdis/pneumoconiosis.
11. Grellier L, Astoul P: Mesothelioma and asbestos-related pleural siseases. Respiration 2008; 76:1-15.
12. Jick H, Jick SS, Derby LE: Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991; 302: 766-768.
13. Jick H, Terris BZ, Derby LE, Jick SS: Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992; 1: 347-349.
14. Hubbard R, Venn A, Lewis S, Britton J: Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000; 161:5-8. (Pubitemid 30055895)
15. Turner S, McNamee R, Carder M, Aguis R: Trends in pneumoconiosis and other lung diseases, as reported to a UK-based surveillance scheme for work-related ill-health. J Phys Conf Ser 2009; 151: 012009.
16. The NHS Plan: A Plan for Investment. A Plan for Reform. London, Stationery Office, 2000. http://www.nhs.uk/nhsplan.
17. British Thoracic Society and Standards of Care Committee: The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Thorax 1999; 54(suppl 1):S1-S28.
18. American Thoracic Society; European Respiratory Society: American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165:277-304.